CD16+CD57- natural killer cells in multifocal motor neuropathy

European Neurology

Volumn 53, Issue 2, 2005, Pages 64-67

  Mizutani, K ^a   Oka, N ^b   Kaji, R ^c   Matsui, M ^a   Asanuma, K ^c   Kubori, T ^d   Kojima, Y ^e   Kanda, M ^e   Kawanishi, T ^f   Tomimoto, H ^a   Akiguchi, I ^a   Shibasaki, H ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b National Hospital Organization Minami Kyoto Hospital   (Japan)

^c TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

^d SUMITOMO HOSPITAL   (Japan)

^e TAKEDA GENERAL HOSPITAL   (Japan)

^f KANSAI DENRYOKU HOSPITAL   (Japan)

Author keywords

Cyclophosphamide; Fc receptor; Intravenous immunoglobulin; Multifocal motor neuropathy; Natural killer cells

Indexed keywords

CD16 ANTIGEN; CD57 ANTIGEN; CYCLOPHOSPHAMIDE; FC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN FC FRAGMENT;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MOTOR NEUROPATHY; NATURAL KILLER CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; AGED; FLOW CYTOMETRY; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION; METABOLISM; MIDDLE AGED; POLYNEUROPATHY;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD57; FEMALE; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; POLYNEUROPATHIES; RECEPTORS, IGG;

EID: 20544456658     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084301     Document Type: Article

References (25)

1. Bobker DH, Deloughery TG: Natural killer cell leukemia presenting with a peripheral neuropathy. Neurology 1993;43:1853-1854.
2. Leitenberg D, Eisen RN, Goldstein JM, Busque L, Rinder HM, Stys P, Katz ME, Gilliland DG, Smith BR: Natural killer cell lymphoproliferative disease associated with neuropathy. Am J Med 1995;99:99-101.
3. Lackowski D, Koberda JL, DeLoughery TG, So Y: Natural killer cell leukemia as a cause of peripheral neuropathy and meningitis: Case report. Neurology 1998;51:640-641.
4. Rabbani GR, Phyliky RL, Tefferi A: A long-term study of patients with chronic natural killer cell lymphocytosis. Br J Haematol 1999;106:960-966.
5. Perussia B, Trinchieri G, Jackson A, Warner NL, Faust J, Rumpold H, Kraft D, Lanier LL: The Fc receptor for IgG on human natural killer cells: Phenotypic, functional, and comparative studies with monoclonal antibodies. J Immunol 1984;133:180-189.
6. Lanier LL, Le AM, Phillips JH, Warner NL, Babcock GF: Subpopulations of human natural killer cells defined by expression of the Leu7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol 1983;131:1789-1796.
7. Kaji R, Kusunoki S, Mizutani K, Oka N, Kojima Y, Kohara N, Kimura J: Chronic motor axonal neuropathy associated with antibodies monospecific for N-acetylgalactosaminyl GD1a. Muscle Nerve 2000;23:702-706.
8. Kaji R, Oka N, Tsuji T, Mezaki T, Nishio T, Akiguchi I, Kimura J: Pathological findings at the site of conduction block in multifocal motor neuropathy. Ann Neurol 1993;33:152-158.
9. Kaji R, Hirota N, Oka N, Kohara N, Watanabe T, Nishio T, Kimura J: Anti-GM1 antibodies and impaired blood-nerve barrier may interfere with remyelination in multifocal motor neuropathy. Muscle Nerve 1994;17:108-110.
10. Aronson FR, Libby P, Brandon EP, Janicka MW, Mier JW: IL-2 rapidly induces natural killer cell adhesion to human endothelial cells: A potential mechanism for endothelial injury. J Immunol 1988;141:158-163.
11. Damle NK, Doyle LV, Bender JR, Bradley EC: Interleukin 2-activated human lymphocytes exhibit enhanced adhesion to normal vascular endothelial cells and cause their lysis. J Immunol 1987;138:1779-1785.
12. Tanaka M, Koike R, Kondo H, Tsuji S, Nagai H: Lymphocyte subsets in amyotrophic lateral sclerosis with motor conduction block. Muscle Nerve 1993;16:116-117.
13. Feldman EL, Bromberg MB, Albers JW, Pestronk A: Immunosuppressive treatment in multifocal motor neuropathy. Ann Neurol 1991;30:397-401.
14. Kaji R, Shibasaki H, Kimura J: Multifocal demyelinating motor neuropathy: Cranial nerve involvement and immunoglobulin therapy. Neurology 1992;42:506-509.
15. Nobile -Orazio E, Meucci N, Barbieri S, Carpo M, Scarlato G: High-dose intravenous immunoglobulin therapy in multifocal motor neuropathy. Neurology 1993;43:537-544.
16. Chaudhry V, Corse AM, Cornblath DR, Kuncl RW, Drachman DB, Freimer ML, Miller RG, Griffin JW: Multifocal motor neuropathy: Response to human immune globulin. Ann Neurol 1993;33:237-242.
17. Donaghy M, Mills KR, Boniface SJ, Simmons J, Wright I, Gregson N, Jacobs J: Pure motor demyelinating neuropathy: Deterioration after steroid treatment and improvement with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry 1994;57:778-783.
18. van den Berg LH, Lokhorst H, Wokke JHJ: Pulsed high-dose dexamethasone is not effective in patients with multifocal motor neuroathy. Neurology 1997;48:1135.
19. Carpo M, Cappellari A, Mora G, Pedotti R, Barbieri S, Scarlato G, Nobile-Orazio E: Deterioration of multifocal motor neuropathy after plasma exchange. Neurology 1998;50:1480-1482.
20. Pestronk A, Cornblath DR, Ilyas AA, Baba H, Quarles RH, Griffin JW, Alderson K, Adams RN: A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 1988;24:73-78.
21. Engelhard D, Waner JL, Kapoor N, Good RA: Effect of intravenous immune globulin on natural killer cell activity: Possible association with autoimmune neutropenia and idiopathic thrombocytopenia. J Pediatr 1986;108:77-81.
22. Créange A, Gregson NA, Hughes RAC: Intravenous immunoglobulin modulates lymphocyte CD54 and monocyte FcγR II expression in patients with chronic inflammatory neuropathies. J Neuroimmunol 2003;135:91-95.
23. Goss GD, Wittwer MA, Bezwoda WR, Herman J, Rabson A, Seymour L, Derman DP, Mendelow B: Effect of natural killer cells on syngeneic bone marrow: In vitro and in vivo studies demonstrating graft failure due to NK cells in an identical twin treated by bone marrow transplantation. Blood 1985;66:1043-1046.
24. Tefferi A, Greipp PR, Leibson PJ, Thibodeau SN: Demonstration of clonality, by X-linked DNA analysis, in chronic natural killer cell lymphocytosis and successful therapy with oral cyclophosphamide. Leukemia 1992;6:477-480.
25. Oshimi K, Yamada O, Kaneko T, Nishinarita S, Iizuka Y, Urabe A, Inamori T, Asano S, Takahashi S, Hattori M, Naohara T, Ohira Y, Togawa A, Masuda Y, Okubo Y, Furusawa S, Sakamoto S, Omine M, Mori M, Tatsumi E, Mizoguchi H: Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders. Leukemia 1993;7:782-788.